A phase I trial of recombinant vaccinia virus, PROSTVAC, that expresses prosatet specific antigen as a vaccine in men with advanced prostate cancer. - Eder,J.P.; Kantoff,P.W.; Bubley,G.J.; Conner,L.A. (Proc Am Soc Clin Oncol, 1998)